Facebook
Twitter
LinkedIn
Forward4th Annual Midwest Endoscopy Group Meeting: Advances in Endoscopy That Affect Your Daily Practice (Virtual Conference, Central Time)
Program Overview
This activity focuses on advances in GI Endoscopy.
Target Audience
This activity is designed to meet the needs of gastroenterologists, oncologists, radiologists, surgeons, advanced prescribing practitioners, and GI nurses.
Objectives
- Describe the latest innovations in endoscopic technology to treat multiple gastrointestinal diseases
- Identify the current application and complementary use of endoscopic versus surgical intervention
- Illustrate, for the health care team, how your clinical gastrointestinal practice can be best improved by learning new endoscopic techniques
Elements of Competence
This activity has been designed to change learner competence and focuses on the American Board of Medical Specialties areas of patient care and procedural skills, practice based learning and improvement, and medical knowledge, in addition to the interprofessional competencies of roles/responsibilities and teams/teamwork.
Saturday, December 5, 2020
| 7:45 AM | Welcome |
WHAT'S NEW IN ACHALASIA AND BARIATRIC ENDOSCOPY, Moderators: Madhusudhan Sanaka, MD, Cleveland Clinic; Sreenivasa Jonnalagadda, MD, St. Luke's Hospital of Kansas City; Venkata Muddana, MD, GI Associates, Milwaukee | |
| 8:00 AM | New Evidence for POEM - Time to Abandon Heller, John DeWitt, MD, Indiana University |
| 8:15 AM | When POEM Fails - Is Heller Still an Option, Jon Gould, MD, MBA, Medical College of Wisconsin |
| 8:30 AM | Bariatric Endoscopy - Ablate, Restrict, Bypass, Vladimir Kushnir, MD, Washington University |
| 8:45 AM | Discussion |
INTERVENTIONAL EUS - WHAT IS THE EVIDENCE, Moderators: Kulwinder Dua, MD, Medical College of Wisconsin; Deepak Gopal, MD, University of Wisconsin | |
| 9:00 AM | Death of the Needle: Should FNA Be Abandoned for FNB, Michelle Anderson, MD, University of Michigan |
| 9:15 AM | Gastrojejunostomy for Malignant Obstruction - Is Surgery Necessary, Irving Waxman, MD, University of Chicago |
| 9:30 AM | Endoscopic Gallbladder Drainage - When Should You Do It, Shawn Mallery, MD, University of Minnesota |
| 9:45 AM | Discussion |
| 10:00 AM | Break |
WHAT IS NEW IN ERCP, Moderators: Nalini Guda, MD, GI Associates, Milwaukee; John Bosco, MD, Aurora Baycare, Green Bay; Srinevas Reddy, MD, Ascension Hospitals, Milwaukee; Srinadh Komanduri, MD, Northwestern University | |
| 10:15 AM | Choledocholithisias in Gastric Bypass Patients - Can Endoscopists Do It Alone, Prabhleen Chahal, MD, Cleveland Clinic |
| 10:30 AM | Biliary Drainage in Cholangiocarcinoma - Stenting the Right Way, Martin Freeman, MD, University of Minnesota |
| 10:45 AM | HCC - Surgery/IR/Transplant - Where Do We Start, Sebouh Gueyikian, MD, Aurora St. Luke's Medical Center, Milwaukee |
| 11:00 AM | Discussion |
COLONOSCOPY IN PRACTICE - ARE WE DOING IT RIGHT, Moderators: Patrick Pfau, MD, University of Wisconsin; Abdul Aziz Aadam, MD, Northwestern University; Molly Meyers, MD, Aurora St. Luke's Medical Center, Milwaukee | |
| 11:15 AM | Clinical Versus Mucosal Remission - When is Endoscopy Necessary to Assess Mucosal Healing in IBD, Anita Afzali, MD, The Ohio State University Wexner Medical Center |
| 11:30 AM | Is Colonoscopy Still Relevant for Screening in the Era of Stool DNA Testing, Nimish Vakil, MD, Aurora Health Care, Milwaukee |
| 11:45 AM | Polyp Resection Techniques - What is New, Douglas Rex, MD, Indiana University |
| 12:00 PM | When is a Polyp Too Large? Surgery Versus ESD - Who Do I Refer To, Amit Bhatt, MD, Cleveland Clinic |
| 12:15 PM | Break |
| 12:30 PM | IDCA Oration: Artificial Intelligence in Endoscopy - Revolutionizing Early Cancer Detection, Prateek Sharma, MD, University of Kansas |
| 12:50 PM | Adjourn |
This is a virtual conference (central time). Please see the Program for further information.
A link to the conference webinar will be sent to enrollees via email prior to the event.
CONFERENCE FACULTY
Anita Afzali, MD, The Ohio State University Wexner Medical Center, Columbus, OH
Michelle Anderson, MD, University of Michigan, Ann Arbor, MI
Abdul Aziz Aadam, MD, Northwestern University, Chicago, IL
Amit Bhatt, MD, Cleveland Clinic, Cleveland, OH
John Bosco, MD, Aurora Baycare, Green Bay, WI
Prabhleen Chahal, MD, Cleveland Clinic, Cleveland, OH
John DeWitt, MD, Indiana University, Indianapolis, IN
Kulwinder Dua, MD, Medical College of Wisconsin, Milwaukee, WI
Martin Freeman, MD, University of Minnesota, Minneapolis, MN
Deepak Gopal, MD, University of Wisconsin, Madison, WI
Jon Gould, MD, MBA, Medical College of Wisconsin, Milwaukee, WI
Nalini Guda, MD, GI Associates, Milwaukee, WI
Sebouh Gueyikian, MD, Aurora St. Luke's Medical Center, Milwaukee, WI
Sreenivasa Jonnalagadda, MD, St. Luke's Hospital of Kansas City, Kansas City, MO
Srinadh Komanduri, MD, Northwestern University, Chicago, IL
Vladimir Kushnir, MD, Washington University, St. Louis, MO
Shawn Mallery, MD, University of Minnesota, Minneapolis, MN
Molly Meyers, MD, Aurora St. Luke's Medical Center, Milwaukee, WI
Venkata Muddana, MD, GI Associates, Milwaukee, WI
Patrick Pfau, MD, University of Wisconsin, Madison, WI
Srinevas Reddy, MD, Ascension Hospitals, Milwaukee, WI
Douglas Rex, MD, Indiana University, Indianapolis, IN
Madhusudhan Sanaka, MD, Cleveland Clinic, Cleveland, OH
Prateek Sharma, MD, University of Kansas, Lawrence, KS
Nimish Vakil, MD, Aurora Health Care, Milwaukee, WI
Irving Waxman, MD, University of Chicago, Chicago, IL
POLICY ON DISCLOSURE
It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) that the faculty, authors, planners, and other persons who may influence content of this continuing education (CE) activity disclose all relevant financial relationships with commercial interests* in order to allow CE staff to identify and resolve any potential conflicts of interest. Faculty must also disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation. For this educational activity all conflicts of interest have been resolved and detailed disclosures are listed below.
NAME |
ROLE |
FINANCIAL RELATIONSHIPS DISCLOSURE | DISCUSSION OF UNLABELED/ UNAPPROVED USES OF DRUGS/DEVICES IN PRESENTATION? |
Anita Afzali, MD | Speaker | AbbVie, Takeda Medical Research Foundation, Janssen Biotech, Celgene, Pfizer (Contractor for All) | No |
Michelle Anderson, MD | Speaker | Boston Scientific Corporation, GlaxoSmithKline, LLC., Boehringer Ingelheim (Contractor for All) | No |
Aziz Aadam, MD | Moderator | Boston Scientific, Steris Endoscopy (Contractor for All) | No |
Amit Bhatt, MD | Speaker | Boston Scientific, Intuitive Surgery, Lumendi, Steris (Contractor for All) | No |
John Bosco, MD | Moderator | No relevant financial relationships to disclose | No |
Prabhleen Chahal, MD | Speaker | Medtronic (Contractor) | Yes |
John DeWitt, MD | Speaker | Vyaire Medical, Inc. (Grant); Boston Scientific Corporation (Contractor) | Yes |
Kulwinder Dua, MD | Planner, Moderator | Boston Scientific Corporation (Contractor) | No |
Martin Freeman, MD | Speaker | No relevant financial relationships to disclose | No |
Deepak Gopal, MD | Moderator | No relevant financial relationships to disclose | No |
Jon Gould, MD, MBA | Speaker | W. L. Gore & Associates, Inc., BARD, Ethicon (Contractor for All) | No |
Nalini Guda, MD | Planner, Moderator | Boston Scientific Corporation (Contractor) | No |
Sebouh Gueyikian, MD | Speaker | No relevant financial relationships to disclose | No |
Sreenivasa Jonnalagadda, MD | Moderator | No relevant financial relationships to disclose | Yes |
Srinadh Komanduri, MD | Moderator | No relevant financial relationships to disclose | Yes |
Amy Komp, RN | Planner | No relevant financial relationships to disclose | No |
Vladimir Kushnir, MD | Speaker | Medtronic USA, Inc., Boston Scientific Corporation (Contractor for Both) | No |
J. Shawn Mallery, MD | Speaker | Boston Scientific Corporation (Contractor) | Yes |
Cathy Means, MS | Planner | No relevant financial relationships to disclose | No |
Molly Meyers, MD | Moderator | No relevant financial relationships to disclose | No |
Venkata Muddana, MD | Moderator | No relevant financial relationships to disclose | No |
Patrick Pfau, MD | Planner, Moderator | No relevant financial relationships to disclose | Yes |
Srinevas Reddy, MD | Moderator | No relevant financial relationships to disclose | No |
Douglas Rex, MD | Speaker | EndoAid, Olympus America Inc., Braintree Laboratories, Medivators Inc., ERBE USA Inc. (Grant for All); Lumendi, Ltd, Braintree Laboratories, Covidien, Endokey, GI Supply, Inc., Olympus America Inc., Aries Pharmaceuticals, Inc., Norgine, Boston Scientific Corporation (Contractor for All); Satisfai Health (Other) | No |
Madhusudhan Sanaka, MD | Moderator | No relevant financial relationships to disclose | No |
Prateek Sharma, MD | Speaker | Boston Scientific Corporation, Medtronic, Bausch, Olympus, Lumendi (Contractor for All); FUJIFILM Holdings America Corporation, US Endoscopy, Olympus, Docbot, CDx Labs, Cosmo Pharmaceuticals, Ironwood Pharmaceuticals, Inc., ERBE USA Inc., Medtronic USA, Inc. (Grant for All) | No |
Nimish Vakil, MD | Speaker | Merck, AstraZeneca, Phathom, Otsuka America Pharmaceutical, Inc. (Contractor for All); Ironwood Pharmaceuticals, Inc. (Aurora Health Care: Grant) | No |
Irving Waxman, MD | Speaker | Auris Medical, BSCI, Medtronic (Contractor for All) | No |
*The ACCME defines a commercial interest as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The ACCME does not consider providers of clinical services directly to patients to be commercial interests.
 | Accreditation StatementIn support of improving patient care, this activity has been planned and implemented by the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) and the Midwest Endoscopy Group Inc. Education Research Consortium. The University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. |
American Medical Association (AMA) | Credit Designation StatementThe University of Wisconsin–Madison ICEP designates this live activity for a maximum of 4.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. |
 | ABIM MOC StatementAmerican Board of Internal Medicine: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 4.25 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. |
CONTINUING EDUCATION UNITS | The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for .425 continuing education units (CEUs) or 4.25 hours |
Available Credit
- 4.25 MOC: ABIM Medical Knowledge Points (Part II)
- 4.25 AMA PRA Category 1 Credit™
- 4.25 University of Wisconsin–Madison Continuing Education Hours
- 4.25 Approved for AMA PRA Category 1 Credit™